These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 22839360)

  • 1. Molecular structure of human GM-CSF in complex with a disease-associated anti-human GM-CSF autoantibody and its potential biological implications.
    Blech M; Seeliger D; Kistler B; Bauer MM; Hafner M; Hörer S; Zeeb M; Nar H; Park JE
    Biochem J; 2012 Oct; 447(2):205-15. PubMed ID: 22839360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Autoantibody against granulocyte-macrophage colony-stimulating factor and other serum markers in pulmonary alveolar proteinosis].
    Xu KF; Chen Y; Guo ZJ; Zhu YJ
    Zhonghua Jie He He Hu Xi Za Zhi; 2004 Dec; 27(12):824-8. PubMed ID: 15730782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoantibodies against granulocyte macrophage colony-stimulating factor are diagnostic for pulmonary alveolar proteinosis.
    Bonfield TL; Russell D; Burgess S; Malur A; Kavuru MS; Thomassen MJ
    Am J Respir Cell Mol Biol; 2002 Oct; 27(4):481-6. PubMed ID: 12356582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Why does the autoantibody against granulocyte-macrophage colony-stimulating factor cause lesions only in the lung?
    Nakata K; Kanazawa H; Watanabe M
    Respirology; 2006 Jan; 11 Suppl():S65-9. PubMed ID: 16423275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Granulocyte-macrophage colony-stimulating factor and lung immunity in pulmonary alveolar proteinosis.
    Tazawa R; Hamano E; Arai T; Ohta H; Ishimoto O; Uchida K; Watanabe M; Saito J; Takeshita M; Hirabayashi Y; Ishige I; Eishi Y; Hagiwara K; Ebina M; Inoue Y; Nakata K; Nukiwa T
    Am J Respir Crit Care Med; 2005 May; 171(10):1142-9. PubMed ID: 15735059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-GM-CSF antibodies in paediatric pulmonary alveolar proteinosis.
    Latzin P; Tredano M; Wüst Y; de Blic J; Nicolai T; Bewig B; Stanzel F; Köhler D; Bahuau M; Griese M
    Thorax; 2005 Jan; 60(1):39-44. PubMed ID: 15618581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Idiopathic pulmonary alveolar proteinosis as an autoimmune disease with neutralizing antibody against granulocyte/macrophage colony-stimulating factor.
    Kitamura T; Tanaka N; Watanabe J; Uchida ; Kanegasaki S; Yamada Y; Nakata K
    J Exp Med; 1999 Sep; 190(6):875-80. PubMed ID: 10499925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-affinity autoantibodies specifically eliminate granulocyte-macrophage colony-stimulating factor activity in the lungs of patients with idiopathic pulmonary alveolar proteinosis.
    Uchida K; Nakata K; Trapnell BC; Terakawa T; Hamano E; Mikami A; Matsushita I; Seymour JF; Oh-Eda M; Ishige I; Eishi Y; Kitamura T; Yamada Y; Hanaoka K; Keicho N
    Blood; 2004 Feb; 103(3):1089-98. PubMed ID: 14512323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GM-CSF autoantibodies and neutrophil dysfunction in pulmonary alveolar proteinosis.
    Uchida K; Beck DC; Yamamoto T; Berclaz PY; Abe S; Staudt MK; Carey BC; Filippi MD; Wert SE; Denson LA; Puchalski JT; Hauck DM; Trapnell BC
    N Engl J Med; 2007 Feb; 356(6):567-79. PubMed ID: 17287477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A cell-free assay to estimate the neutralizing capacity of granulocyte-macrophage colony-stimulating factor autoantibodies.
    Urano S; Kaneko C; Nei T; Motoi N; Tazawa R; Watanabe M; Tomita M; Adachi T; Kanazawa H; Nakata K
    J Immunol Methods; 2010 Aug; 360(1-2):141-8. PubMed ID: 20621102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The mechanism of GM-CSF inhibition by human GM-CSF auto-antibodies suggests novel therapeutic opportunities.
    Dhagat U; Hercus TR; Broughton SE; Nero TL; Cheung Tung Shing KS; Barry EF; Thomson CA; Bryson S; Pai EF; McClure BJ; Schrader JW; Lopez AF; Parker MW
    MAbs; 2018 Oct; 10(7):1018-1029. PubMed ID: 29969365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serological diagnosis of idiopathic pulmonary alveolar proteinosis.
    Kitamura T; Uchida K; Tanaka N; Tsuchiya T; Watanabe J; Yamada Y; Hanaoka K; Seymour JF; Schoch OD; Doyle I; Inoue Y; Sakatani M; Kudoh S; Azuma A; Nukiwa T; Tomita T; Katagiri M; Fujita A; Kurashima A; Kanegasaki S; Nakata K
    Am J Respir Crit Care Med; 2000 Aug; 162(2 Pt 1):658-62. PubMed ID: 10934102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disseminated Cryptococcosis Due to Anti-Granulocyte-Macrophage Colony-Stimulating Factor Autoantibodies in the Absence of Pulmonary Alveolar Proteinosis.
    Kuo CY; Wang SY; Shih HP; Tu KH; Huang WC; Ding JY; Lin CH; Yeh CF; Ho MW; Chang SC; He CY; Chen HK; Ho CH; Lee CH; Chi CY; Ku CL
    J Clin Immunol; 2017 Feb; 37(2):143-152. PubMed ID: 28013480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoantibody-Mediated Pulmonary Alveolar Proteinosis in Rasgrp1-Deficient Mice.
    Ferretti A; Fortwendel JR; Gebb SA; Barrington RA
    J Immunol; 2016 Jul; 197(2):470-9. PubMed ID: 27279372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct evidence that GM-CSF inhalation improves lung clearance in pulmonary alveolar proteinosis.
    Ohashi K; Sato A; Takada T; Arai T; Nei T; Kasahara Y; Motoi N; Hojo M; Urano S; Ishii H; Yokoba M; Eda R; Nakayama H; Nasuhara Y; Tsuchihashi Y; Kaneko C; Kanazawa H; Ebina M; Yamaguchi E; Kirchner J; Inoue Y; Nakata K; Tazawa R
    Respir Med; 2012 Feb; 106(2):284-93. PubMed ID: 22112784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of activin A in autoimmune lung disease associated with anti-GM-CSF.
    Bonfield TL; Barna BP; John N; Malur A; Culver DA; Kavuru MS; Thomassen MJ
    J Autoimmun; 2006 Feb; 26(1):37-41. PubMed ID: 16337108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced GM-CSF autoantibody in improved lung of autoimmune pulmonary alveolar proteinosis.
    Ohashi K; Sato A; Takada T; Arai T; Kasahara Y; Hojo M; Nei T; Nakayama H; Motoi N; Urano S; Eda R; Yokoba M; Tsuchihashi Y; Nasuhara Y; Ishii H; Ebina M; Yamaguchi E; Inoue Y; Nakata K; Tazawa R
    Eur Respir J; 2012 Mar; 39(3):777-80. PubMed ID: 22379153
    [No Abstract]   [Full Text] [Related]  

  • 18. Characterization of pathogenic human monoclonal autoantibodies against GM-CSF.
    Wang Y; Thomson CA; Allan LL; Jackson LM; Olson M; Hercus TR; Nero TL; Turner A; Parker MW; Lopez AL; Waddell TK; Anderson GP; Hamilton JA; Schrader JW
    Proc Natl Acad Sci U S A; 2013 May; 110(19):7832-7. PubMed ID: 23620516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Granulocyte/macrophage-colony-stimulating factor autoantibodies and myeloid cell immune functions in healthy subjects.
    Uchida K; Nakata K; Suzuki T; Luisetti M; Watanabe M; Koch DE; Stevens CA; Beck DC; Denson LA; Carey BC; Keicho N; Krischer JP; Yamada Y; Trapnell BC
    Blood; 2009 Mar; 113(11):2547-56. PubMed ID: 19282464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IgM-type GM-CSF autoantibody is etiologically a bystander but associated with IgG-type autoantibody production in autoimmune pulmonary alveolar proteinosis.
    Nei T; Urano S; Motoi N; Takizawa J; Kaneko C; Kanazawa H; Tazawa R; Nakagaki K; Akagawa KS; Akasaka K; Ichiwata T; Azuma A; Nakata K
    Am J Physiol Lung Cell Mol Physiol; 2012 May; 302(9):L959-64. PubMed ID: 22367782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.